Veery Capital, LLC

Position in LLY — ELI LILLY & Co

CIK 1844375 Wilmington, DE

Position in LLY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$369,424

+$84,296 QoQ

Shares Held

308

-0.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.91%

of 13F equity value

Holder Rank

#4,003

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Veery Capital, LLC holds $1,998,644 across 6 Drug Manufacturers - General names. LLY ranks #2 (18.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,691	$429,463
2	LLY	ELI LILLY & Co This page	308	$369,424
3	MRK	Merck & Co., Inc.	2,664	$342,324
4	AZN	Astrazeneca PLC	1,787	$338,850
5	GILD	Gilead Sciences, Inc.	2,330	$294,372
6	ABBV	AbbVie Inc.	891	$224,211

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$369,424	308	-0.6%	Shares	Sole	2026-07-09
2026-03-31	$285,128	310	-0.3%	Shares	Sole	2026-04-09
2025-12-31	$334,225	311	+0.3%	Shares	Sole	2026-01-27
2025-09-30	$236,530	310	0.0%	Shares	Sole	2025-10-15
2025-06-30	$241,654	310	-2.5%	Shares	Sole	2025-07-07
2025-03-31	$262,639	318	-3.0%	Shares	Sole	2025-04-08
2024-12-31	$253,216	328	+1.5%	Shares	Sole	2025-01-15
2024-09-30	$286,158	323	-3.9%	Shares	Sole	2024-11-06
2024-06-30	$304,207	336	-0.6%	Shares	Sole	2024-07-18
2024-03-31	$262,950	338	-4.2%	Shares	Sole	2024-04-19
2023-12-31	$205,770	353	—	Shares	Sole	2024-01-10
No filing history on record for this holder in this stock.